INVESTIGATIONAL Preclinical‑stage. Not approved by FDA.
INVESTIGATIONAL Under development. Not cleared by FDA.

January 2024

All news, publications, and updates from Seek Labs.

  • Seek Labs Invited to Present at BIO CEO & Investor Conference

    Seek Labs Invited to Present at BIO CEO & Investor Conference

    Seek Labs Invited to Present at BIO CEO & Investor Conference January 30, 2024 SALT LAKE CITY, UT, January 30, 2024 (BusinessWire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced its upcoming participation at the BIO CEO & Investor Conference, which will take place in New…

Stay connected

Follow the work as it unfolds.

Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.